Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1924 participants.
Also called NCT05893498
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 1,924 participants
- Registry
-
NCT05893498
-
- Other papers using this trial's data
- Angiography-Derived Fractional Flow Reserve to Guide PCI
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Israel, Japan, Switzerland, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05893498. Randomized; no masking; primary purpose diagnostic. Start 2023-06-21 (actual); primary completion 2026-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment
- Acronym
- ALL-RISE
- Condition
- Percutaneous Coronary Intervention
- Intervention (Device)
- FFRangio
- Intervention (Device)
- FFR or NHPR
- Lead sponsor
- CathWorks Ltd.
- Collaborator
- Cardiovascular Research Foundation, New York
Record details
- Record id
cardio:ct-nct05893498- Content hash
e9d6cbed3a8b4c117b412069a5f5ea7560738d68bc59fc3bb40f3beeeae33a61